Research Article
Prognostic Value of Plasma Pentraxin-3 Levels in Patients with Stable Coronary Artery Disease after Drug-Eluting Stent Implantation
Table 4
Univariate and multivariate Cox regression analysis of major adverse cardiovascular events.
| Variables | Univariate analysis RR (95% CI) | | Multivariate analysis RR (95% CI) | |
| Age | 1.072 (1.040–1.106) | 0.000 | 1.041 (1.008–1.074) | 0.013 | Male | 1.002 (0.587–1.709) | 0.994 | | | CCSA > II | 1.762 (1.137–2.730) | 0.011 | 1.009 (0.563–1.808) | 0.874 | LVEF < 50% | 1.662 (1.069–2.585) | 0.024 | 1.061 (0.591–1.906) | 0.842 | Diabetes mellitus | 1.760 (1.053–2.940) | 0.031 | 1.234 (0.677–2.250) | 0.493 | Hypertension | 1.125 (0.725–1.744) | 0.599 | | | Hyperlipidemia | 1.096 (0.694–1.731) | 0.693 | | | Current smoking | 1.254 (0.797–1.973) | 0.327 | | | PTX3 | 3.233 (1.968–5.311) | 0.000 | 2.512 (1.466–4.305) | 0.001 | cTnI | 1.029 (1.011–1.047) | 0.002 | 1.012 (1.004–1.284) | 0.008 | HsCRP | 1.832 (1.529–2.195) | 0.000 | 1.093 (0.998–1.197) | 0.056 | Multiple stents | 2.694 (1.724–4.211) | 0.000 | 2.401 (1.479–3.899) | 0.0004 |
|
|
Abbreviations as in Table 1.
|